PDS Biotechnology Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Freitag Gregory Gene | — | Purchase | 15,060 | $1.66 | $25,000 | Feb 28, 2025 |
| Glover Stephen C. | — | Purchase | 15,061 | $1.66 | $25,001 | Feb 28, 2025 |
| BEDU-ADDO FRANK | President/CEO | Option Exercise | 219,535 | $6.57 | $1,442,345 | Dec 2, 2022 |
| HILL MATTHEW C | Chief Financial Officer | Purchase | 100 | $9.00 | $900 | Dec 13, 2021 |
| Bloomquist DeLyle W | — | Option Exercise | 2,970 | $5.99 | $17,790 | Jun 16, 2021 |
| BEDU-ADDO FRANK | President/CEO | Option Exercise | 53,174 | $6.57 | $349,353 | Jun 15, 2021 |
| Glover Steve C | — | Purchase | 5,882 | $8.50 | $49,997 | Jun 15, 2021 |
| Ali-Jackson Kamil | — | Purchase | 11,764 | $8.50 | $99,994 | Jun 15, 2021 |
| VAN VOORHEES SETH | Chief Financial Officer | Purchase | 17,647 | $8.50 | $150,000 | Jun 15, 2021 |
| Freitag Gregory Gene | — | Purchase | 5,882 | $8.50 | $49,997 | Jun 15, 2021 |
| Freitag Gregory Gene | — | Award / Grant | 38,400 | $1.30 | $49,920 | Feb 14, 2020 |
| SYKES RICHARD | — | Award / Grant | 384,615 | $1.30 | $500,000 | Feb 14, 2020 |
| Saik Andrew | Chief Financial Officer | Award / Grant | 38,400 | $1.30 | $49,920 | Feb 14, 2020 |
| Glover Steve C | — | Award / Grant | 38,400 | $1.30 | $49,920 | Feb 14, 2020 |
| Macdonald R. Loch | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| Spiegel Robert J. | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| Saik Andrew | Chief Financial Officer | Option Exercise | 82,999 | — | — | Mar 15, 2019 |
| Ratcliffe Liam | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| MIDDLEKAUFF W BRADFORD | Senior VP, GC and Secretary | Option Exercise | 49,766 | — | — | Mar 15, 2019 |
| LOUGHLIN JAMES J | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| Leuthner Brian A | President and CEO | Option Exercise | 169,032 | — | — | Mar 15, 2019 |
| BLECH ISAAC | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| BLECH ISAAC | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| Crane Rosemary A | — | Option Exercise | 10,000 | — | — | Mar 15, 2019 |
| BARER SOL J | — | Option Exercise | 20,000 | — | — | Mar 15, 2019 |
| Conti Kurt G | — | Other | 58,476 | — | — | Mar 23, 2018 |
| Macdonald R. Loch | Chief Scientific Officer | Sale | 2,500 | $16.41 | $41,025 | Mar 22, 2018 |
| Macdonald R. Loch | Chief Scientific Officer | Sale | 2,500 | $16.52 | $41,300 | Mar 19, 2018 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $14.81 | $37,025 | Mar 2, 2018 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $15.47 | $38,675 | Feb 23, 2018 |
| Macdonald R. Loch | Chief Scientific Officer | Sale | 2,500 | $14.49 | $36,225 | Feb 21, 2018 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $12.96 | $32,400 | Feb 1, 2018 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $10.11 | $25,275 | Jan 2, 2018 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $9.68 | $24,200 | Dec 4, 2017 |
| MARCHIO ALBERT N II | Chief Accounting & Adm Officer | Sale | 3,361 | $10.00 | $33,610 | Nov 22, 2017 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $10.92 | $27,300 | Nov 2, 2017 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $10.81 | $27,025 | Oct 3, 2017 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $9.94 | $24,850 | Sep 6, 2017 |
| MARCHIO ALBERT N II | Chief Accounting & Adm Officer | Sale | 2,500 | $10.42 | $26,050 | Aug 29, 2017 |
| MARCHIO ALBERT N II | Chief Accounting & Adm Officer | Sale | 1,000 | $10.39 | $10,390 | Aug 23, 2017 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $10.65 | $26,625 | Aug 2, 2017 |
| BARER SOL J | — | X | 12,530 | $2.39 | $29,947 | Jul 7, 2017 |
| Leuthner Brian A | President and CEO | Sale | 2,500 | $10.21 | $25,525 | Jul 3, 2017 |
| Leuthner Brian A | President and CEO | Sale | 100 | $11.10 | $1,110 | Apr 26, 2017 |
| LOUGHLIN JAMES J | — | Purchase | 3,000 | $9.24 | $27,720 | Mar 6, 2017 |
| Einhorn Andrew J. | Chief Financial Officer | X | 1,567 | $2.39 | $3,745 | Mar 1, 2017 |
| Leuthner Brian A | President and CEO | Sale | 1,500 | $9.52 | $14,280 | Feb 7, 2017 |
| Leuthner Brian A | President and CEO | Sale | 1,500 | $9.69 | $14,535 | Feb 6, 2017 |
| Leuthner Brian A | President and CEO | Sale | 1,500 | $9.38 | $14,070 | Feb 2, 2017 |
| Macdonald R. Loch | Chief Scientific Officer | Option Exercise | 25,000 | $2.04 | $51,000 | Jan 23, 2017 |